Health Care & Life Sciences » Pharmaceuticals | Canopy Growth Corp.

Canopy Growth Corp. | Mutual Funds

Mutual Funds that own Canopy Growth Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
2,489,835
1.12%
36,500
0.03%
07/31/2018
2,334,846
1.05%
13,376
14.61%
07/31/2018
1,099,203
0.5%
0
10.99%
09/06/2018
Vanguard Developed Markets Index Fund
990,848
0.45%
-816
0.04%
07/31/2018
Manulife Canadian Focused Fund
635,115
0.28%
-2,937,423
3.66%
12/31/2017
British Columbia Inv Management Corp.
606,000
0.27%
606,000
0.03%
03/31/2017
Canadian General Investments Ltd.
500,000
0.23%
500,000
3.23%
06/30/2018
Vanguard FTSE All World (ex-US) Small Cap
444,476
0.2%
18,756
0.3%
07/31/2018
437,812
0.2%
437,812
1.45%
06/29/2018
TD Emerald Canadian Equity Index Fund
372,800
0.17%
33,700
0.46%
12/31/2017

About Canopy Growth

View Profile
Address
1 Hershey Drive
Smith Falls Ontario K7A 0A8
Canada
Employees -
Website http://www.canopygrowth.com
Updated 07/08/2019
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules, and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite.